Hap Trading, LLC Cytokinetics Inc Put Options Transaction History

Hap Trading, LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	BUY	$51.22 - $60.16 $1.79 Million - $2.11 Million	35,000 Added 57.85%	95,500 $3.15 Billion
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $38.4 Million - $60.2 Million	-801,800 Reduced 92.98%	60,500 $2.78 Billion
Q1 2024 May 13, 2024	BUY	$63.75 - $108.06 $45.4 Million - $77 Million	712,300 Added 474.87%	862,300 $7.83 Billion
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $1.99 Million - $6.17 Million	73,900 Added 97.11%	150,000 $2.76 Million
Q3 2023 Nov 09, 2023	BUY	$29.46 - $36.61 $2.24 Million - $2.79 Million	76,100 New	76,100 $2.24 Million
Q3 2021 Nov 10, 2021	SELL	$18.54 - $35.74 $285,516 - $550,396	-15,400 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$19.79 - $26.99 $304,766 - $415,646	15,400 New	15,400 $107,000
Q1 2021 May 14, 2021	SELL	$18.57 - $25.68 $737,229 - $1.02 Million	-39,700 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $1.12 Million - $2.11 Million	-73,600 Reduced 64.96%	39,700 $170,000
Q3 2020 Nov 13, 2020	BUY	$20.58 - $28.96 $2.33 Million - $3.28 Million	113,300 New	113,300 $306,000
Q2 2020 Aug 10, 2020	SELL	$11.15 - $24.64 $129,340 - $285,824	-11,600 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$8.75 - $16.3 $101,500 - $189,080	11,600 New	11,600 $18,000

405

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.78B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.